XML 174 R50.htm IDEA: XBRL DOCUMENT v3.25.1
Long-Term Investments (Details) - USD ($)
3 Months Ended 12 Months Ended
Jan. 01, 2025
Oct. 31, 2021
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jun. 30, 2024
May 24, 2024
Mar. 14, 2024
Long-Term Investments [Line Items]                  
Percentage of common stock shares   51.00%   51.00%          
Aggregate amount           $ 2,688,578      
Prepayment amount           $ 1,895,556      
Converted shares     994,450     994,450      
Common stock, shares authorized     100,000,000 100,000,000 [1] 100,000,000 [1]        
Ordinary shares issued     15,378,305 13,868,484 [1] 7,940,298 [1]       1,610,700
Ordinary shares outstanding     15,378,305 13,868,484 [1] 7,940,298 [1]        
Payment to joint venture   $ 150,000   $ 150,000          
BioFirst Corporation [Member]                  
Long-Term Investments [Line Items]                  
Percentage of common stock shares     18.68% 18.68% 18.68%        
Prepayment amount       $ 1,124,842          
Ordinary shares issued   3,049   3,049          
Ordinary shares outstanding   3,049   3,049          
Rgene Corporation (the “Rgene”) [Member]                  
Long-Term Investments [Line Items]                  
Percentage of common stock shares 37.00%   26.65% 26.65% 26.65%        
BioLite Japan K.K. [Member]                  
Long-Term Investments [Line Items]                  
Percentage of common stock shares   49.00%   49.00%          
Common stock, shares authorized   10,000   10,000          
Payment to joint venture   $ 150,000   $ 150,000          
BioLite JP [Member]                  
Long-Term Investments [Line Items]                  
Owned shares   1,494   1,494          
Common Stock [Member]                  
Long-Term Investments [Line Items]                  
Ordinary shares issued             41,387 200,000  
Common Stock [Member] | Lucidaim Co Ltd [Member]                  
Long-Term Investments [Line Items]                  
Owned shares   1,555   1,555          
[1] Prior period results have been adjusted to reflect the 1-for-10 reverse stock split effected on July 25, 2023.